Trial Profile
A Placebo-controlled Trial With Prucalopride for the Treatment of Typical Reflux Symptoms in Patients With Gastro-esophageal Reflux Disease With Incomplete Proton Pump Inhibitor Response
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Prucalopride (Primary) ; Proton pump inhibitors
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 17 Aug 2018 New trial record